Should You Forget SpaceX (SPCX) Stock?

SpaceX revenue jumped 92% year over year to $7.8B in Q2, but it still posted a net loss of $541M (improving from a $1B loss a year earlier). Despite analysts’ optimism—average 1-year target of $222 vs. ~$150—valuation risk is high with a price-to-sales ratio of ~65 and an extremely rich forward-looking P/E of ~194. The article also flags potential stock pressure from over $1B of early-investor share “unlocks” in September/October.

Analysis

The market is pricing SpaceX like a near-monopoly platform, but the valuation already discounts years of flawless execution. In the near term, the more important event is the unlock window: incremental insider supply can reset the marginal clearing price even if operating metrics stay strong. If secondary transactions reprice lower, that can spill into the late-stage private tech complex and compress sentiment for other “category killer” names that still have no earnings.

Competitive dynamics are more nuanced than the headline growth rate suggests. The company’s scale is a moat, but it also pushes launch and satellite pricing lower, which is hostile to smaller launch operators and legacy satellite bandwidth providers over 6-18 months. Public comparables most exposed are high-duration aerospace/space names such as RKLB and IRDM; the risk is not a direct read-through to their revenue, but a multiple reset if investors decide SpaceX can keep funding growth without paying the same cost of capital as public peers.

The contrarian point: the consensus is overconfident that growth alone will justify the premium. What matters is conversion of revenue into durable free cash flow, and the article gives no evidence that the business is close to that inflection. If margins do not inflect over the next 1-3 quarters, the stock can de-rate quickly because there is no earnings anchor. The thesis is falsified if the unlock is absorbed cleanly, secondary prices hold near current levels, and operating leverage appears in the next report.

Key Decisions for Investors

• Avoid initiating new risk in SPCX ahead of the September-October unlock; wait for secondary pricing to clear, since a 10-20% discount to current implied value would argue for another leg lower.
• Use RKLB as the cleanest public hedge on space-duration sentiment: short on unlock weakness in SPCX, with a 1-3 month horizon and a stop if RKLB re-rates on improving launch cadence or margin guidance.
• If you want a relative-value expression, pair short IRDM against a broader market basket only if SpaceX pricing signals intensify; the risk/reward is best when secondary prices show persistent weakness, not on the first headline.
• Set an alert on SPCX secondary trades and next quarter gross margin/cash burn: if the unlock clears without discount and margin improves, cover any bearish exposure quickly; that would invalidate the de-rating thesis.